bioAffinity Technologies, Inc.'s total assets for Q2 2025 were $4.75M, a decrease of -14.35% from the previous quarter. BIAF total liabilities were $6.89M for the fiscal quarter, a 67.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.